Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1786-2010

directCHECK Whole Blood Control; for Hemochron J. Microcoagulation Systems

Accriva Diagnostics, Inc. / initiated 2010-04-15 / Terminated / root cause: labeling and UDI

International Technidyne Corporation began a recall of directCHECK Whole Blood Control; for Hemochron J. Microcoagulation Systems on . The reason FDA records is "Indication not cleared or approved. The acceptable performance range published in the directCHECK Microcoagulation Quality Control package insert is incorrect". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1786-2010
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Accriva Diagnostics, Inc.
Product
directCHECK Whole Blood Control; for Hemochron J. Microcoagulation Systems.
Product code
GGN Plasma, Coagulation Control
Reason for recall
Indication not cleared or approved. The acceptable performance range published in the directCHECK Microcoagulation Quality Control package insert is incorrect.
Root cause tag
labeling and UDI
FDA root cause
Error in labeling
Action
Notification letters were sent vis Federal Express on April 15, 2010 to all distributors and end users to return unused product or to replace the package insert. Please direct questions ITC Technical Support at phone 800-631-5945 Ext. 4707.
Quantity in commerce
94 boxes
Distribution
Distributors and medical facilities in AZ, CA, IL, KY, MA, MD, ME, MO, PA, WA. Foreign distribution to Australia, Canada, Switzerland, Germany, Spain, Quatar, and Saudi Arabia.
Product codes and lots
Catalog number.Code number: DCJPT-A; Lot number G9DPA005; Exp. 1/31/2011.